TagsFamily Medicine 
AQUIPTA®

AQUIPTA® (Atogepant) ABBVIE HK Reg. No. HK-68287 (03 Jul, 2024) & HK-68288 (03 Jul, 2024) Composition: 1 Aquipta® (Atogepant) is an orally administered, small molecule, selective calcitonin gene-related peptide (CGRP) receptor antagonist...

Oct 22, 2024
AMOROLFINE®

AMOROLFINE® (Amorolfine hydrochloride) NOVARTIS HK-68364 (09 Sept, 2024) Composition: 3 AMOROLFINE® (amorolfine hydrochloride) is a topical antimycotic. Amorolfine belongs to a new chemical class, and its fungicidal action is based on an alt...

Oct 22, 2024
LEQEMBI®

LEQEMBI® (lecanemab) EISAI HK Reg. No. HK-68289 (03 Jul, 2024) & HK-68290 (03 Jul, 2024) Composition: 3 LEQEMBI® is an amyloid beta-directed antibody with the active ingredient lecanemab-irmb. It is administered as an intravenous infusio...

Aug 20, 2024
AKEEGA™

AKEEGA™ (niraparib and abiraterone acetate) JOHNSON & JOHNSON HK Reg. No. HK-68296 (09 Jul, 2024) & HK-68295 (09 Jul, 2024) Composition: 2 AKEEGA™ is a combination of niraparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, an...

Aug 20, 2024
LITFULO™

LITFULO™ (ritlecitinib) PFIZER HK Reg. No. HK-68283 (28 Jun, 2024) Composition: 4 LITFULO™ is a kinase inhibitor available in the form of capsule with 50 mg ritlecitinib. Indication: 4 LITFULO™ is indicated for the treatment of sev...

Aug 20, 2024
What’s New in Coronary Artery Disease?

Coronary artery disease (CAD) is a significant health challenge, imposing substantial burdens on individuals and healthcare systems worldwide. Notably, in Hong Kong, 1.6% of those aged 15 or above are reported as doctor-diagnosed CAD, with a higher ...

Aug 20, 2024
The Unmet Needs in Relapse/ Refractory Multiple Myeloma: A Clinical Challenge

Multiple myeloma (MM) is a haematologic malignancy characterised by abnormal clonal plasma cells in the bone marrow with a potential for uncontrolled growth causing destruction, osseous lesion, acute kidney injury (AKI), anaemia, and hypercalcaemia....

Aug 20, 2024
Clinical Strategies on Prescribing Long-acting Injectable Antipsychotics in Managing Schizophrenia

Schizophrenia is a psychiatric syndrome of delusions, disorganised speech, hallucinations, and impaired executive functioning1. Despite affecting approximately 1% of the global population, poor treatment adherence remains as an unmet need associated...

Aug 20, 2024
Is Gene Therapy or Bioartificial Organs the Future of Medical Treatment?

Rare diseases typically have a prevalence below 0.05% and constitute around 10,000 diseases, cumulatively affecting over 5% of the global population. Although there is a large unmet need in treatment, the recent advent of gene therapy is beginning t...

Aug 20, 2024
Therapeutic Treatments to Cope with a Love Breakup

The hottest love has the coldest end.” Facing a romantic relationship breakup can be devastating, overwhelming and heart-wrenching. There has been an increasing trend of divorce over the last 3 decades in Hong Kong, with the crude divorce rate...

Aug 20, 2024
The Role of Matrix Metalloproteases in Tendinopathy and Its Clinical Implications

Tendinopathies are generally referred to as conditions including chronic pain and rupture in tendons. Since inflammatory cells are usually absent in the lesion, tendinopathy has long been recognised as a degenerative condition. Accordingly, anti-inf...

Aug 20, 2024